The Sagol Institute for Longevity Research coordinates scientific activities that show promise for significantly increasing our understanding of the aging process. A special emphasis is placed on those projects that have the potential for contributing new knowledge and approaches that might someday be applied to improving health and increasing human life span.

Neurobiology research is providing important insights about the healthy brain as well as neurodegenerative conditions. This type of research has tremendous potential for increasing the quality and length of life for millions of individuals.
Metabolism and nutrition are inextricably linked, and contribute to conditions, like diabetes and obesity, that shorten human life. Research related to metabolic diseases may result in new treatments and lifestyle strategies that will contribute to human longevity.
Cardiovascular diseases are the leading cause of death in most of the world. Weizmann Institute research is leading to new approaches that point the way toward clinical strategies for early diagnosis, prevention, and treatment.
Bone and muscle-related diseases, such as osteoporosis, arthritis, and fibromyalgia, prey disproportionally upon the elderly. Study of these conditions by Weizmann Institute scientists is revealing important insights about the aging process.
Sensory losses--in vision, hearing, smell, taste and even touch--dramatically decrease the quality of life among the elderly. Research in Weizmann Institute labs is helping to characterize these phenomena, paving the way toward new approaches for reducing the severity of age-related symptoms.